Aluminum exposure from parenteral nutrition in preterm infants: Bone health at 15-year follow-up

Pediatrics

Volumn 124, Issue 5, 2009, Pages 1372-1379

  Fewtrell, Mary S ^a   Bishop, Nick J ^b   Edmonds, Caroline J ^a   Isaacs, Elizabeth B ^a   Lucas, Alan ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b SHEFFIELD CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Aluminum; Bone health; Parenteral nutrition; Preterm infant

Indexed keywords

ALUMINUM; BRONCHODILATING AGENT; CORTICOSTEROID;

ADOLESCENT; ARTICLE; ASTHMA; BONE; BONE MASS; BONE MINERAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EXPOSURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HIP; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; PREMATURITY; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ALUMINUM; BONE AND BONES; BONE DENSITY; COGNITION; FOLLOW-UP STUDIES; FOOD, FORMULATED; HIP JOINT; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LUMBAR VERTEBRAE; PARENTERAL NUTRITION; WHOLE BODY IMAGING;

EID: 70350489228     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2009-0783     Document Type: Article

References (19)

1. Gura KM, Puder M. Recent developments in aluminum contamination of products used in parenteral nutrition. Curr Opin Clin Nutr Metab Care. 2006;9(3):239-246 (Pubitemid 44097835)
2. Poole RL, Hintz SR, Mackenzie NI, Kerner JA. Aluminum exposure from pediatric parenteral nutrition: meeting the new FDA regulation. JPEN J Parenter Enteral Nutr. 2008; 32(3):242-246
3. McGraw M, Bishop N, Jameson R, et al. Aluminum content of milk formulae and intravenous fluids used in infants. Lancet. 1986; 1(8473):157 (Pubitemid 16183131)
4. Moreno A, Dominguez C, Ballabriga A. Aluminum in the neonate related to parenteral nutrition. Acta Paediatr. 1994;83(1):25-29
5. Bishop NJ, Robinson MJ, Lendon M, Hewitt CD, Day JP, O'Hara M. Increased concentration of aluminum in the brain of a parenterally fed preterm infant. Arch Dis Child. 1989;64(9):1316-1317 (Pubitemid 19220783)
6. Bishop NJ, Morley R, Day JP, Lucas A. Aluminum neurotoxicity in preterm infants receiving intravenous-feeding solutions. N Engl J Med. 1997;336(22):1557-1561 (Pubitemid 27231156)
7. Klein G. Metabolic bone disease of total parenteral nutrition. Nutrition. 1998;14(1): 149-152 (Pubitemid 28049002)
8. Sedman AB, Klein GL, Russell MD, et al. Evidence of aluminum loading in infants receiving intravenous therapy. N Engl J Med. 1985;312(21):1337-1343
9. Nelson M, Hague GF, Cooper C, Bunker VW. Calcium intake in the elderly: validation of a dietary questionnaire. J Hum Nutr Diet. 1988;1(1):115-127 (Pubitemid 19041733)
10. Bishop N, Braillon P, Burnham J, et al. Dualenergy X-ray absorptiometry assessment in children and adolescents with diseases that may affect the skeleton: the 2007 ISCD Pediatric Official Positions. J Clin Densitom. 2008;11(1):29-42
11. Crabtree NJ, Oldroyd B, Truscott JG, et al. UK Paediatric reference data (GE Lunar Prodigy). Osteoporos Int. 2004. Available at: www. springerlink.com/content/fy43tewe1x4w91x1/ fulltext.pdf. Accessed September 23, 2009
12. Cole TJ. Sympercents: symmetric percentage differences on the 100 log(e) scale simplify the presentation of log transformed data. Stat Med. 2000;19(22):3109-3125
13. Fewtrell MS, Cole TJ, Bishop NJ, Lucas A. Neonatal factors predicting childhood height in preterm infants: evidence for a persisting effect of early metabolic bone disease? J Pediatr. 2000;137(5):668-673 (Pubitemid 30840125)
14. Fewtrell MS, Williams JE, Singhal A, Murgatroyd PR, Fuller N, Lucas A. Early diet and peak bone mass: 20 year follow-up of a randomized trial of early diet in infants born preterm. Bone. 2009;45(1):142-149
15. Elefteriou F. Regulation of bone remodelling by the central and peripheral nervous system. Arch Biochem Biophys. 2008;473(2): 231-236
16. Fewtrell MS. Osteoporosis: is primary prevention possible? In: Lucas A, Sampson HA, eds. Primary Prevention by Nutrition Intervention in Infancy and Childhood. Nestle Nutrition Workshop Series Pediatric Program 57. Basel, Switzerland: Karger, Vevey, Switzerland: Nestec Ltd. 2006;135-152
17. Cirmanová V, Beyer M, Starka L, Zajickova K. The effect of leptin on bone: an evolving concept of action. Physiol Res. 2008;57(suppl 1):S143-S151
18. Fewtrell MS, Kennedy K, Singhal A, et al. How much loss to follow-up is acceptable in long-term randomised trials and prospective studies? Arch Dis Child. 2008;93(6): 458-461 (Pubitemid 352025759)
19. Hernandez CJ. Theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis. Osteoporos Int. 2003; 14(10):843